フォロー
Hirokazu Makishima
Hirokazu Makishima
確認したメール アドレス: pmrc.tsukuba.ac.jp
タイトル
引用先
引用先
Progressive hypofractionated carbon‐ion radiotherapy for hepatocellular carcinoma: combined analyses of 2 prospective trials
G Kasuya, H Kato, S Yasuda, H Tsuji, S Yamada, Y Haruyama, G Kobashi, ...
Cancer 123 (20), 3955-3965, 2017
822017
Risk of subsequent primary cancers after carbon ion radiotherapy, photon radiotherapy, or surgery for localised prostate cancer: a propensity score-weighted, retrospective …
O Mohamad, T Tabuchi, Y Nitta, A Nomoto, A Sato, G Kasuya, ...
The lancet oncology 20 (5), 674-685, 2019
812019
Proton beam therapy combined with concurrent chemotherapy for esophageal cancer
H Ishikawa, T Hashimoto, T Moriwaki, I Hyodo, K Hisakura, H Terashima, ...
Anticancer research 35 (3), 1757-1762, 2015
802015
Carbon-ion radiation therapy for pelvic recurrence of rectal cancer
S Yamada, T Kamada, DK Ebner, M Shinoto, K Terashima, Y Isozaki, ...
International Journal of Radiation Oncology* Biology* Physics 96 (1), 93-101, 2016
752016
Evolution of carbon ion radiotherapy at the National Institute of Radiological Sciences in Japan
O Mohamad, H Makishima, T Kamada
Cancers 10 (3), 66, 2018
742018
Comparison of adverse effects of proton and X-ray chemoradiotherapy for esophageal cancer using an adaptive dose–volume histogram analysis
H Makishima, H Ishikawa, T Terunuma, T Hashimoto, K Yamanashi, ...
Journal of radiation research 56 (3), 568-576, 2015
652015
Proton beam therapy for metastatic liver tumors
N Fukumitsu, T Okumura, D Takizawa, H Makishima, H Numajiri, ...
Radiotherapy and Oncology 117 (2), 322-327, 2015
422015
Single fraction carbon ion radiotherapy for colorectal cancer liver metastasis: a dose escalation study
H Makishima, S Yasuda, Y Isozaki, G Kasuya, N Okada, M Miyazaki, ...
Cancer science 110 (1), 303-309, 2019
252019
Long-term results of high-dose 2-fraction carbon ion radiation therapy for hepatocellular carcinoma
S Yasuda, H Kato, H Imada, Y Isozaki, G Kasuya, H Makishima, H Tsuji, ...
Advances in Radiation Oncology 5 (2), 196-203, 2020
222020
Cancer‐specific mortality of high‐risk prostate cancer after carbon‐ion radiotherapy plus long‐term androgen deprivation therapy
G Kasuya, H Ishikawa, H Tsuji, Y Haruyama, G Kobashi, DK Ebner, ...
Cancer science 108 (12), 2422-2429, 2017
202017
Updated long‐term outcomes after carbon‐ion radiotherapy for primary renal cell carcinoma
G Kasuya, H Tsuji, T Nomiya, H Makishima, Y Haruyama, G Kobashi, ...
Cancer Science 109 (9), 2873-2880, 2018
162018
Prospective clinical trial of 12-fraction carbon-ion radiotherapy for primary renal cell carcinoma
G Kasuya, H Tsuji, T Nomiya, H Makishima, Y Haruyama, G Kobashi, ...
Oncotarget 10 (1), 76, 2019
152019
Significant impact of biochemical recurrence on overall mortality in patients with high‐risk prostate cancer after carbon‐ion radiotherapy combined with androgen deprivation …
G Kasuya, H Ishikawa, H Tsuji, T Nomiya, H Makishima, T Kamada, ...
Cancer 122 (20), 3225-3231, 2016
142016
First prospective feasibility study of carbon-ion radiotherapy using compact superconducting rotating gantry
T Bhattacharyya, M Koto, H Ikawa, K Hayashi, Y Hagiwara, H Makishima, ...
The British Journal of Radiology 92 (1103), 20190370, 2019
112019
A retrospective study of late adverse events in proton beam therapy for prostate cancer
H Makishima, H Ishikawa, K Tanaka, Y Mori, M Mizumoto, K Ohnishi, ...
Molecular and Clinical Oncology 7 (4), 547-552, 2017
102017
Carbon-ion radiotherapy for colorectal cancer
S Yamada, H Takiyama, Y Isozaki, M Shinoto, H Makishima, N Yamamoto, ...
Journal of the Anus, Rectum and Colon 5 (2), 113-120, 2021
92021
Carbon‐ion radiotherapy versus radiofrequency ablation as initial treatment for early‐stage hepatocellular carcinoma
N Fujita, N Kanogawa, H Makishima, S Ogasawara, S Maruta, Y Iino, ...
Hepatology Research 52 (12), 1060-1071, 2022
52022
Olfactory sensations during proton and photon radiotherapy: A multicenter prospective observational study
M Mizumoto, Y Oshiro, T Sumiya, T Miyamoto, K Baba, M Murakami, ...
Cureus 14 (3), 2022
52022
Assessment of SPECT-CT fusion images and semi-quantitative evaluation using SUV in 123I-IMP SPECT in patients with choroidal melanoma
K Yamazaki, R Nishii, T Maeda, H Makishima, G Kasuya, T Chang, ...
Annals of nuclear medicine 34, 864-872, 2020
52020
Heavy charged particles for gastrointestinal cancers
Y Isozaki, H Takiyama, T Bhattacharyya, D Ebner, G Kasuya, ...
Journal of Gastrointestinal Oncology 11 (1), 203, 2020
52020
現在システムで処理を実行できません。しばらくしてからもう一度お試しください。
論文 1–20